for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

J&J scraps late-stage study testing Stelara for lupus

June 26 (Reuters) - Johnson & Johnson’s Janssen unit said on Friday it would discontinue a late-stage study testing its psoriatic arthritis drug Stelara as a treatment for lupus due to lack of efficacy.

Systemic Lupus Erythematosus, or lupus, is a chronic disease that causes inflammation in connective tissues, such as cartilage and the lining of blood vessels. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Saumyadeb Chakrabarty)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up